https://doi.org/10.7490/f1000research.1115026.1
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
268
 
downloads
15
CITE
How to cite this poster:
Zubov D, Vasyliev R and Oksymets V. Ukrainian biomedical tissue-engineered product for treatment of bone critical sized defects and avn: manufacturing and first-in-human clinical outcomes [version 1; not peer reviewed]. F1000Research 2017, 6:1918 (poster) (https://doi.org/10.7490/f1000research.1115026.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Ukrainian biomedical tissue-engineered product for treatment of bone critical sized defects and avn: manufacturing and first-in-human clinical outcomes

Author Affiliations
  • Metrics
  • 268 Views
  • 15 Downloads
 
Part of the collection
Browse by related subjects
Published 31 Oct 2017

Ukrainian biomedical tissue-engineered product for treatment of bone critical sized defects and avn: manufacturing and first-in-human clinical outcomes

[version 1; not peer reviewed]

Author Affiliations
1 A.A. PARTNERS LLC. (Medical company ilaya®), State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Ukraine
2 A.A. PARTNERS LLC. (Medical company ilaya®), Ukraine
Presented at
Integrative Biology & Medicine 2017
Abstract
Competing Interests

The study was conducted by employees from Medical company ilaya (A.A. PARTNERS LLC.). Ukrainian volunteer center “Peoples project” provided financial support as charity for study participants, who suffered during the fighting in the East of Ukraine. ILAYA SCIENCE LLC. is coordinating the research and processing of statistical data obtained during the study by the Agreement on cooperation with A.A. PARTNERS LLC. The poster was created by the employee from ILAYA SCIENCE LLC. (Kristina Hantseva). According to the research data was created a Ukrainian patent "MEDICAL PRODUCT BASED ON HUMAN CELLS FOR CORRECTION OF OSTEOREPARATIVE PROCESSES" No. 115089 and an application PCT/UA2016/000128 “METHOD OF THE OSTEOREPARATIVE PROCESSES’ CORRECTION AND /OR BONE DEFECT RESTORATION BY MEANS OF HUMAN CELL-BASED MEDICINAL PRODUCTS (CELL AND/OR TISSUE TRANSPLANTS) AND/OR METHOD OF THEIR MANUFACTURING”. There are no political, religious, or ideological competing interests.

Keywords
stem cells, tissue-engineered bone equivalent, critical sized bone defects, avascular necrosis, regenerative medicine, tissue engineering
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.